| abstract |
Compounds of the formula I (See formula (I)) are provided, wherein R1, R6 R8, Q2, Q3a, Q4, L and A have the meanings given in the description and their pharmaceutically acceptable salts, compounds that are useful in the treatment of diseases in which it is desired and / or requires the inhibition of the activity of a member of the MAPEG family, and in particular in the treatment of inflammation and / or cancer. |